Cervical cancer prevention in HIV-infected women using the "see and treat" approach in botswana

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 3, 2012, Pages 308-313

  Ramogola Masire, Doreen ^a,b,c   De Klerk, Ronny ^a   Monare, Barati ^a   Ratshaa, Bakgaki ^a   Friedman, Harvey M ^a,b   Zetola, Nicola M ^a,b,c  

^a BOTSWANA UPENN PARTNERSHIP   (Botswana)

^b UNIVERSITY OF BOTSWANA   (Botswana)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Africa; Cervical cancer; EDI; HPV; Prevention; VIA

Indexed keywords

ACETIC ACID;

ADULT; ARTICLE; BOTSWANA; CANCER GRADING; CANCER INVASION; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; COLPOSCOPY; CRYOTHERAPY; DIGITAL IMAGING; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NURSE; PATIENT REFERRAL; PRECANCER; PRIORITY JOURNAL; PUNCH BIOPSY; QUALITY CONTROL; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VAGINAL INTRAEPITHELIAL NEOPLASIA;

ACETIC ACID; BOTSWANA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CRYOTHERAPY; FEMALE; HIV; HIV INFECTIONS; HUMANS; STATISTICS, NONPARAMETRIC; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84859735698     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182426227     Document Type: Article

References (34)

1. Cervical cancer screening in developing countries. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2002: ISBN 92 4 1545720.
2. World Health Organization. Human papillomavirus vaccines. Geneva, Switzerland; 2009. Available at: http: //www.who.int/wer/2009/wer8415.pdf. Accessed May 1, 2011.
3. Hawes SE, Critchlow CW, Faye Niang MA, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003; 188: 555-563. (Pubitemid 37011808)
4. Firnhaber C, Evans D, Friedman-Khalili R, et al. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol. 2011; 52: 265-268.
5. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008; 123: 153-160. (Pubitemid 351705203)
6. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006; 24(suppl 3): S3/71-S3/77.
7. Finn A. HPV prevention: waiting for screening services. Lancet. 2010; 375: 1694.
8. Danso D, Lyons F, Bradbeer C. Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women. Int J STD AIDS. 2006; 17: 579-584; quiz: 585-577.
9. Kim JJ, Brisson M, Edmunds WJ, et al. Modeling cervical cancer prevention in developed countries. Vaccine. 2008; 26(suppl 10): K76-K86.
10. Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst. 2009; 101: 1612-1623.
11. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001; 79: 954-962. (Pubitemid 33027175)
12. De Vuyst H, Franceschi S. Human papillomavirus vaccines in HIV-positive men and women. Curr Opin Oncol. 2007; 19: 470-475. (Pubitemid 47356604)
13. De Vuyst H, Lillo F, Broutet N, et al. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008; 17: 545-554.
14. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency viruspositive women. J Natl Cancer Inst. 2005; 97: 577-586. (Pubitemid 40723785)
15. van der Burg SH, Palefsky JM. Human immunodeficiency virus and human papilloma virus-why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med. 2009; 7: 108.
16. Central Statistics Office, Republic of Botswana. Stats Brief: Preliminary Results of the AIDS Impact Survey III. Gaborone, Botswana: 2008.
17. International Group on Analysis of Trends in HIV Prevalence and Behaviours in Young People in Countries most Affected by HIV. Trends in HIV prevalence and sexual behaviour among young people aged 15-24 years in countries most affected by HIV. Sex Transm Infect. 2010; 86(suppl 2): ii72-ii83.
18. Bussmann H, de la Hoz Gomez F, Roels TH, et al. Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-threshold survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. AIDS Res Hum Retroviruses. 2011; 27: 365-372.
19. Riviello ED, Sterling TR, Shepherd B, et al. HIV in the workplace in Botswana: incidence, prevalence, and disease severity. AIDS Res Hum Retroviruses. 2007; 23: 1453-1460.
20. Macleod IJ, O'Donnell B, Moyo S, et al. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana. J Med Virol. 2011; 83: 1689-1695.
21. Ramogola-Masire D, McGrath CM, Barnhart KT, et al. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana. Int J Gynecol Pathol. 2011; 30: 591-596.
22. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007; 370: 398-406. (Pubitemid 47176655)
23. Sankaranarayanan R, Mathew B, Jacob BJ, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000; 88: 664-673. (Pubitemid 30056944)
24. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360: 1385-1394.
25. Sankaranarayanan R, Shyamalakumary B, Wesley R, et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer. 1999; 80: 161-163. (Pubitemid 28559793)
26. Nene BM, Deshpande S, Jayant K, et al. Early detection of cervical cancer by visual inspection: a population-based study in rural India. Int J Cancer. 1996; 68: 770-773. (Pubitemid 27062039)
27. Berkhof J, de Bruijne MC, Zielinski GD, et al. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer. 2006; 118: 1759-1768. (Pubitemid 43376440)
28. Sankaranarayanan R, Nene BM, Dinshaw K, et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex. 2003; 45(suppl 3): S399-S407. (Pubitemid 38029656)
29. Nene BM, Hiremath PS, Kane S, et al. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet. 2008; 103: 232-236.
30. Gage JC, Rodriguez AC, Schiffman M, et al. An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women. Int J Gynecol Cancer. 2009; 19: 728-733.
31. Gage JC, Rodriguez AC, Schiffman M, et al. Treatability by cryotherapy in a screen-and-treat strategy. J Low Genit Tract Dis. 2009; 13: 174-181.
32. Blumenthal PD, Lauterbach M, Sellors JW, et al. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005; 89(suppl 2): S30-S37.
33. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008; 26(suppl 10): K29-K41.
34. Quinley KE, Gormley RH, Ratcliffe SJ, et al. Use of mobile telemedicine for cervical cancer screening. J Telemed Telecare. 2011; 17: 203-209.